Deep Vein Thrombosis: Difference between revisions

Jump to:navigation,search
No edit summary
No edit summary
Line 3: Line 3:
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}  [[Image:Leg veins.png|right|100px]]
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}  [[Image:Leg veins.png|right|100px]]
==Clinically Relevant Anatomy==
==Introduction==
Deep Vein Thrombosis(DVT)when one or morebloodclots formina deep veinof thebody.Themost commonsiteforDVT is inthelower limbs.Kesieme E, Kesieme C, Jebbin N, Irekpita E, Dongo A. Deep vein thrombosis: a clinical review. J Blood Med 2011; 2:59–69.Proximal DVTsofthe lower extremity(LE)involve the popliteal and/or thigh veins(femoral vein, external iliac vein, deep vein of the thigh), while distal DVTs encompass those that develop in the calf.
A deep-vein thrombosis(DVT)abloodclot that forms within the deep veins, usually of the leg, but can occurinthe veinsof thearms and the mesenteric and cerebral veins.
* A common and important disease.
* It is part of the venous thromboembolism disorders which represent the thirdmost commoncause of death from cardiovascular disease after heart attacks and stroke.
* Accountformost cases of pulmonary embolism. Only through early diagnosis and treatment canthemorbidity be reducedKesieme E, Kesieme C, Jebbin N, Irekpita E, Dongo A. Deep vein thrombosis: a clinical review. J Blood Med 2011; 2:59–69..
*即使在没有得到肺栓塞的病人, recurrent thrombosis and "post-thrombotic syndrome" are a major causeofmorbidity.Waheed SM, Kudaravalli P, Hotwagner DT. [https://www.ncbi.nlm.nih.gov/books/NBK507708/ Deep vein thrombosis(DVT)]. StatPearls [Internet]. 2020 Aug 10. Available from:https://www.ncbi.nlm.nih.gov/books/NBK507708/ (last accessed 25.10.2020)


DVTs in the upper extremity (UE) are less common (4-10% of all cases).=":2">Heil J, Miesbach W, Vogl T, Bechstein WO, Reinisch A. Deep vein thrombosis of the upper extremity: A systematic review. Dtsch Arztebl Int 2017; 114(14): 244–249 The deep veins of the upper extremity include the jugular, brachiocephalic, subclavian, and axillary veins proximally and the brachial, ulnar, and radial veins distally. In the upper extremity, the subclavian, jugular and axillary veins are the primary vessels in which DVTs form.=":2" />Joffe H, Kucher N, Tapson V, Goldhaber S. Upper-extremity deep vein thrombosis: a prospective registry of 593 patients. Circulation 2004; 110: 1605-1611
==Pathophysiology==
== Pathological Process==
血栓由于hypercoagulation一个发展d stasis around venous valve sinuses. The majority of deep vein thrombi start in the calf.Kearon C. Natural history of venous thromboembolism. Seminars in Vascular Medicine 2001; 01(1): 027-038 These clots are firm and are mostly made up of fibrin and red blood cells ([http://www.topnews.in/health/files/Deep-Vein-Thrombosis.jpg see the image of a DVT here]). On autopsy, the majority are attached to venous walls.
Within 72 hours, an estimated 50% of intraoperative calf DVTs resolve on their own. About 1 in 6 of these extend into the proximal veins of the leg, causing venous obstruction and damage to affected valves. A subset of proximal DVT becomes mobile and progresses to [https://emedicine.medscape.com/article/300901-overview pulmonary embolism] (PE), a potentially fatal condition. The incidence of PE is more common in LE than UE DVTs.


According to Virchow's triad, the following are the main pathophysiological mechanisms involved in DVT:
* Damage to the vessel wall
* Blood flow turbulence
* Hypercoagulability
DVT is commonest in the lower limb below the knee and starts at low-flow sites, such as the soleal sinuses, behind venous valve pockets.Joffe H, Kucher N, Tapson V, Goldhaber S. Upper-extremity deep vein thrombosis: a prospective registry of 593 patients. Circulation 2004; 110: 1605-1611.Kearon C. Natural history of venous thromboembolism. Seminars in Vascular Medicine 2001; 01(1): 027-038
* Clots are firm and are mostly made up of fibrin and red blood cells ([http://www.topnews.in/health/files/Deep-Vein-Thrombosis.jpg see the image of a DVT here]). On autopsy, the majority are attached to venous walls.
* Within 72 hours, an estimated 50% of intraoperative calf DVTs resolve on their own.
* About 1 in 6 of these extend into the proximal veins of the leg, causing venous obstruction and damage to affected valves.
* A subset of proximal DVT becomes mobile and progresses to [https://emedicine.medscape.com/article/300901-overview pulmonary embolism] (PE), a potentially fatal condition.
The following video provides a visual representation of DVT pathology:
The following video provides a visual representation of DVT pathology:
{{#ev:youtube|0QEo9QAqA3k}}
{{#ev:youtube|0QEo9QAqA3k}}


== Risk Factors ==
== Risk Factors ==
Variousrisk factorsplay in the formation of DVTs. In adults, blood clotting disordersareassociated with spontaneous formation. Several other clinical factors augment patient riskaswell:1" />
Following are therisk factorsandareconsideredascauses of deep venous thrombosis:
{| class="wikitable"
*Reduced blood flow: Immobility (bed rest, general anesthesia, operations, [[stroke]], long flights)
!Clinical Condition
*Increased venous pressure: Mechanical compression or functional impairment leading to reduced flow in the veins ([[Oncology|neoplasm]], pregnancy, stenosis,orcongenital anomaly which increases outflow resistance)
!Medical Interventions
*Mechanical injury to the vein: Trauma, surgery, peripherally inserted venous catheters, previous DVT, intravenous drug abuse.
!Environment
*Increased blood viscosity: Polycythaemia rubra vera, thrombocytosis, [[dehydration]]
|-
*Anatomic variations in venous anatomy can contribute to thrombosis.
|
Increased Risk of Coagulation
*Acute Infection
*Genetic deficiencies: Anticoagulation proteins C and S, antithrombin III deficiency, factor V Leiden mutation
*Cancer
*Acquired: Cancer, [[sepsis]], [[Myocardial Infarction|myocardial infarction]], [[Heart Failure|heart failure]], vasculitis, [[Systemic Lupus Erythematosus|systemic lupus erythematosus]] and lupus anticoagulant, [[Irritable Bowel Syndrome|Inflammatorybowel disease]], [[Chronic Kidney Disease|nephrotic]] syndrome, burns, oral estrogens,[[Smoking CessationandBrief Intervention|smoking]], [[Blood Pressure|hypertension]], [[diabetes]]
* Strokeorparalysis
Constitutional Factors
*Previous VTE*
* [[Obesity]],pregnancy, [[Older People-An Introduction|Increasing age]],surgery, andcancer.
* Congestive heart failure
* Pregnancy or peurperium
* [//m.houseofhawgs.com/Dehydration Dehydration]
*Varicose veins
* Nephrotic syndrome
*Rheumatological disease
*Acute inflammatorybowel disease
|
* Hormonal treatment
*[[Chemotherapy Side EffectsandSyndromes|Chemotherapy]]
*避孕药
* Recent major surgery
|
* Prolonged immobility
*Long air travel
|}
[*VTE= venous thromboembolism]
The UE has its own set of additional risk factors:
* Intravenous catheters
* Pacemaker cables
* Anatomical anomalies (ex. shoulder girdle syndrome,clavicular fractures,Paget–von Schroetter syndrome)
Risk factors more prominent in children include[https://www.physio-pedia.com/Sickle_Cell_Anemia sickle cell]disease,severe infection,antiphospholipid syndromesandtrauma.Gertziafas GT. Risk factors for venous embolism in children. Int Angiol 2004;2 3(3):195–205
== Clinical Presentation ==
== Clinical Presentation ==
[[图片:DVT.jpg拇指| | 150 px | DVT的右腿with swelling and redness]]
[[图片:DVT.jpg拇指| | 150 px | DVT的右腿with swelling and redness]]
The clinical presentationofindividuals with DVTisinconsistent,as many patients are asymptomatic. Thosewithsymptoms may demonstrate the following features in the affected extremity:1" />
History
* Discoloration
* Pain (50% of patients)
* Pain/discomfort
* Redness
* Warmth
* Swelling (70%ofpatients)
* Swelling
Physical Examination
* Tenderness
* Limb edema may be unilateral or bilateral if the thrombusisextending to pelvic veins
* Red and hot skin, withdilated veins
* Tenderness9" />
== Clinical Prediction Rule (CPR): Well's Criteria ==
== Clinical Prediction Rule (CPR): Well's Criteria ==


Line 96: 83行:
In the original scale, the total score for all items is tallied and the probability of the patient having a DVT is as follows: 0= low probability, 1-2 points= moderate probability,and ≥ 3 points= high probability.Wells PS, Hirsh J, Anderson DR, Lensing AW, Foster G, Kearon C, Weitz J, D'Ovidio R, Cogo A, Prandoni P. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345(8961):1326-1330 An updated version simplifies the scoring process into two categories: < 2 points= DVT unlikely, ≥ 2 points= DVT likely.Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349:1227–1235
In the original scale, the total score for all items is tallied and the probability of the patient having a DVT is as follows: 0= low probability, 1-2 points= moderate probability,and ≥ 3 points= high probability.Wells PS, Hirsh J, Anderson DR, Lensing AW, Foster G, Kearon C, Weitz J, D'Ovidio R, Cogo A, Prandoni P. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345(8961):1326-1330 An updated version simplifies the scoring process into two categories: < 2 points= DVT unlikely, ≥ 2 points= DVT likely.Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349:1227–1235


好了's Criteria is a valid tool for assessing DVT risk in outpatientWells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L, Clement C, Robinson KS, Lewandowski B. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350(9094):1795-1798Geersing GJ, Zuithoff NPA, Kearon C, Anderson DR, Cate-Hoek T, Elf JL, Bates SM, Hoes AW, Kraaijenhagen RA, Oudega R, Schutgens RE, Stevens SM, Woller SC, Wells PS, Moons KG. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ 2014; 348:g1340 and traumaModi S, Deisler R, Gozel K, Reicks P, Irwin E, Brunsvold M, Banton K, Beilman GJ. Wells criteria for DVT is a reliable clinical tool to assess the risk of deep venous thrombosis in trauma patients. World J Emerg Surg. 2016; 11: 24 patients. It is less useful for stratifying risk in cancer patients and hospitalized patients as a whole.Silveira PC, Ip IK, Goldhaber SZ, Piazza G, Benson CB, Khorasani R. Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting. JAMA Intern Med 2015; 175(7):1112-7 It cannot be used to screen for UE DVT.
好了's Criteria is a valid tool for assessing DVT risk in outpatientWells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L, Clement C, Robinson KS, Lewandowski B. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350(9094):1795-1798Geersing GJ, Zuithoff NPA, Kearon C, Anderson DR, Cate-Hoek T, Elf JL, Bates SM, Hoes AW, Kraaijenhagen RA, Oudega R, Schutgens RE, Stevens SM, Woller SC, Wells PS, Moons KG. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ 2014; 348:g1340 and traumaModi S, Deisler R, Gozel K, Reicks P, Irwin E, Brunsvold M, Banton K, Beilman GJ. Wells criteria for DVT is a reliable clinical tool to assess the risk of deep venous thrombosis in trauma patients. World J Emerg Surg. 2016; 11: 24 patients. It is less useful for stratifying risk in cancer patients and hospitalized patients as a whole.Silveira PC, Ip IK, Goldhaber SZ, Piazza G, Benson CB, Khorasani R. Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting. JAMA Intern Med 2015; 175(7):1112-7 It cannot be used to screen for UE DVT.>Heil J, Miesbach W, Vogl T, Bechstein WO, Reinisch A. Deep vein thrombosis of the upper extremity: A systematic review. Dtsch Arztebl Int 2017; 114(14): 244–249</ref>


== Clinical Tests/Examination ==
== Clinical Tests/Examination ==


The clinical diagnosis of DVT is unreliable. However, in combination with valid screening tools, clinical examination can justify the need for diagnostic testing.
The clinical diagnosis of DVT is unreliable. However, in combination with valid screening tools, clinical examination can justify the need for diagnostic testing.
=== Observation and Palpation ===
* Focuson identifying the signs and symptoms described in the "Clinical Presentation" section of this article.
[[File:Pitting edema.jpg|thumb|Pitting edema]]Clinical observation and palpation should focuson identifying the signs and symptoms described in the "Clinical Presentation" section of this article.
[[Homan's SignTest|Homan's Sign]]
===Homan's Sign===
Homan's Signhas been used as an indicator for LE DVT since the 1940s.Urbano F. Homans' Sign in the Diagnosis of Deep Venous Thrombosis. Hospital Physician 2001. 22-24 The test is performed by forcefully dorsiflexing the ankle while the knee is slightly flexed. Pain and tenderness in the calf are said to be indicative of LE DVT. Despite its historical use, Homan's sign has no diagnostic value.


== Diagnostic Procedures ==
== Diagnostic Procedures ==
Diagnostic testing is the only definitive way to confirm DVT.
=== D-Dimer Testing ===
D-dimer testing is a simple blood test of fibrin degradation. D-dimer levels are increased by any condition that produces fibrin, one of the primary components of deep vein thrombi. The negative likelihood ratio is higher than 99%. According to Wells and colleagues,Riddle DL, Wells PS. Diagnosis of Lower-Extremity Deep Vein Thrombosis in Outpatients. Physical Therapy. 84 (8); 729-735. the test is best used to rule out DVT in outpatients with a low probability of proximal DVT.
=== Venous Ultrasound ===
Venous ultrasound is considered to be the first-choice, diagnostic test for patients who are symptomatic and stratify into the moderate and high probability risk groups for Well's Criteria. The test is a safe, non-invasive and inexpensive. Depending on availability, patient characteristics and the location of the suspected DVT, compression ultrasound, duplex ultrasound or color Doppler imaging may be used. The sensitivity and specificity of compression ultrasonography averages 95% for detection of proximal DVT.
[[Image:Venography.jpg|thumb|200px|Venography]]
[[Image:Venography.jpg|thumb|200px|Venography]]
=== Venography ===
As per the NICE guidelines following investigations are done:
* D-dimers (very sensitive but not very specific)
Venography is consideredthegold standard test forDVT.1" />Thetestis rarely used due to its invasive nature and the availabilityofaccurate, non-invasive options (ex. D-dimerand venous ultrasound). Theprocedure involves an x-ray of the veins (venogram) taken after a special dyeisinjected into the bone marrow or venous vessels.
* Coagulation profile
* Proximal leg vein ultrasound, which when positive, indicates thatthe病人应该be treated as having aDVT9" />
D-Dimer Testing
* D-dimer testing is a simple bloodtest offibrin degradation. D-dimerlevels are increased by any condition that produces fibrin, one of the primary components of deep vein thrombi. Thenegative likelihood ratioishigher than 99%.According to Wells and colleagues,>Riddle DL, Wells PS. Diagnosis of Lower-Extremity Deep Vein Thrombosis in Outpatients. Physical Therapy. 84 (8); 729-735.</ref> the test is best used to rule out DVT in outpatients with a low probability of proximal DVT.>
== Management / Interventions ==
== Management / Interventions ==


Line 206: Line 185:
== Differential Diagnosis ==
== Differential Diagnosis ==


Below is a non-exhaustive list for the differential diagnosis of calf pain in patients with suspected LE DVT:Dutton. Orthopaedic Examination, Evaluation, and Intervention. McGraw Hill; 2004. pg 261, 1338, 1367.
Below is a non-exhaustive list for the differential diagnosis of calf pain in patients with suspected LE DVT:Dutton. Orthopaedic Examination, Evaluation, and Intervention. McGraw Hill; 2004. pg 261, 1338, 1367.>Urbano F. Homans' Sign in the Diagnosis of Deep Venous Thrombosis. Hospital Physician 2001. 22-24</ref>


*Pyomyositis
*Pyomyositis

Revision as of 07:54, 25 October 2020

Introduction[edit|edit source]

深静脉血栓形成(DVT)是一种血液clot that forms within the deep veins, usually of the leg, but can occur in the veins of the arms and the mesenteric and cerebral veins.

  • A common and important disease.
  • It is part of the venous thromboembolism disorders which represent the third most common cause of death from cardiovascular disease after heart attacks and stroke.
  • Account for most cases of pulmonary embolism. Only through early diagnosis and treatment can the morbidity be reduced[1].
  • Even in patients who do not get pulmonary emboli, recurrent thrombosis and "post-thrombotic syndrome" are a major cause of morbidity.[2]

Pathophysiology[edit|edit source]

According to Virchow's triad, the following are the main pathophysiological mechanisms involved in DVT:

  • Damage to the vessel wall
  • Blood flow turbulence
  • Hypercoagulability[2]

DVT is commonest in the lower limb below the knee and starts at low-flow sites, such as the soleal sinuses, behind venous valve pockets.[2][3].[4]

  • Clots are firm and are mostly made up of fibrin and red blood cells[1](see the image of a DVT here). On autopsy, the majority are attached to venous walls.[1]
  • Within 72 hours, an estimated 50% of intraoperative calf DVTs resolve on their own.[4]
  • About 1 in 6 of these extend into the proximal veins of the leg,[4]causing venous obstruction and damage to affected valves.
  • A subset of proximal DVT becomes mobile and progresses topulmonary embolism(PE), a potentially fatal condition.

The following video provides a visual representation of DVT pathology:

Risk Factors[edit|edit source]

Following are the risk factors and are considered as causes of deep venous thrombosis:

  • Reduced blood flow: Immobility (bed rest, general anesthesia, operations,stroke, long flights)
  • Increased venous pressure: Mechanical compression or functional impairment leading to reduced flow in the veins (neoplasm, pregnancy, stenosis, or congenital anomaly which increases outflow resistance)
  • Mechanical injury to the vein: Trauma, surgery, peripherally inserted venous catheters, previous DVT, intravenous drug abuse.
  • Increased blood viscosity: Polycythaemia rubra vera, thrombocytosis,dehydration
  • Anatomic variations in venous anatomy can contribute to thrombosis.

Increased Risk of Coagulation

Constitutional Factors

Clinical Presentation[edit|edit source]

DVT in the right leg with swelling and redness

History

  • Pain (50% of patients)
  • Redness
  • Swelling (70% of patients)

Physical Examination

  • Limb edema may be unilateral or bilateral if the thrombus is extending to pelvic veins
  • Red and hot skin, with dilated veins
  • Tenderness[2]

Clinical Prediction Rule (CPR): Well's Criteria[edit|edit source]

好了's Criteria is the most commonly used tool to screen for DVT risk:[1]

Clinical Variable Score
Active cancer (treatment ongoing or within previous 6 months, or palliative) +1
Paralysis, paresis, or recent plaster immobilization of the lower extremities +1
Recently bedridden for > 3 days or major surgery within 4 weeks +1
Localized tenderness along the distribution of the deep venous system (Tenderness along the deep venous system is assessed by firm palpation in the center of the posterior calf, the popliteal space, and along the area of the femoral vein in the anterior thigh and groin) +1
Entire lower extremity swelling +1
Calf swelling > 3 cm when compared with the asymptomatic lower extremity (measured 10cm below the tibial tuberosity) +1
Pitting edema confined to the symptomatic lower extremity +1
Collateral superficial veins (non-varicose) +1
Alternative diagnosis as likely or greater than that of proximal DVT (More common alternative diagnoses include cellulitis, calf strain, Baker Cyst, or postoperative swelling) -2

In the original scale, the total score for all items is tallied and the probability of the patient having a DVT is as follows: 0= low probability, 1-2 points= moderate probability,and ≥ 3 points= high probability.[5]An updated version simplifies the scoring process into two categories: < 2 points= DVT unlikely, ≥ 2 points= DVT likely.[6]

好了's Criteria is a valid tool for assessing DVT risk in outpatient[7][8]and trauma[9]patients. It is less useful for stratifying risk in cancer patients[8]and hospitalized patients as a whole.[10]It cannot be used to screen for UE DVT.[11]

Clinical Tests/Examination[edit|edit source]

The clinical diagnosis of DVT is unreliable. However, in combination with valid screening tools, clinical examination can justify the need for diagnostic testing.

  • Focus on identifying the signs and symptoms described in the "Clinical Presentation" section of this article.

Homan's Sign

Diagnostic Procedures[edit|edit source]

Venography

As per the NICE guidelines following investigations are done:

  • D-dimers (very sensitive but not very specific)
  • Coagulation profile
  • Proximal leg vein ultrasound, which when positive, indicates that the patient should be treated as having a DVT[2]

D-Dimer Testing

  • D-dimer testing is a simple blood test of fibrin degradation. D-dimer levels are increased by any condition that produces fibrin, one of the primary components of deep vein thrombi. The negative likelihood ratio is higher than 99%. According to Wells and colleagues,[12]the test is best used to rule out DVT in outpatients with a low probability of proximal DVT.

管理/干预[edit|edit source]

Primary Prevention[edit|edit source]

A combination of mechanical and pharmacological measures can be used to prevent DVT. Mechanical prophylaxis involves the use of graduated compression stockings (GCS), intermittent pneumatic compression (IPC) and venous foot pumps to improve blood flow in the deep veins of the leg. Common agents for pharmacological prophylaxis include Warfarin, subcutaneous unfractionated heparin (UFH) and low-molecular-weight heparins (LMWH).[3]DVT prevention is most effective when both methods are used simultaneously.[1]In medical and surgical patients ambulation and exercises involving ankle dorsiflexion are encouraged to further minimize venous stasis.[1]

Medical Treatment[edit|edit source]

Anticoagulation[edit|edit source]

Anticoagulation is the usual treatment for DVT. Patients are generally initiated on a brief course (i.e., less than a week) of heparin treatment.[13]If heparin is contraindicated, fondaparinux (FDX) or direct oral anticoagulants (DOAC) [ex. Xarelto, dabigatran, apixaban] may be used.[1]Acute DVT treatment is followed by a maintenance course (typically 3-6 months) of warfarin or other Vitamin K inhibitor.[1][13]Variations in treatment may exist for patients with delayed removal of an intravenous catheter or an ongoing tumor disease in the case of UE DVT.[11]

Thrombolysis[edit|edit source]

Although rarely indicated, thrombolytic therapy is used to treat extensive blood clots.[1]A meta-analysis of randomized controlled trials by the Cochrane Collaboration[14]shows improved outcomes with thrombolysis, though this benefit comes at the increased risk of serious bleeding complications.

Inferior Vena Cava (IVC) Filter[edit|edit source]

印度河流域文明过滤器s may prevent pulmonary embolisation and is an option for patients with an absolute contraindication to anticoagulant treatment.[15]Most newer filters can be removed at a later date, if desired.[1]Complications of this intervention include filter erosion, filter migration and obstruction of the inferior vena cava.[1]

Secondary Prevention[edit|edit source]

Compression stockings.

Early Mobilization[edit|edit source]

In conjunction with anti-coagulation, bed rest is commonly prescribed in the immediate days following the diagnosis of LE DVT. This practice is applied with the intent of preventing clot dislodgement and the incidence of PE. The theoretical basis behind this protocol has not been supported by the literature.[16][17]According to a systematic review,[17]early ambulation is associated with fewer incidences of new PE and decreased mortality. As such, early mobilization is instrumental for the prevention of DVT sequelae (see the next section on "Implications for Physical Therapy Practice" for guidelines on safe patient mobilization following known DVT).

Graduated Compression Stockings[edit|edit source]

To prevent DVT recurrence, the application of graduated compression stockings is recommended "beginning within 1 month of diagnosis of proximal DVT and continuing for a minimum of 1 year after diagnosis".[18]

Implications for Physical Therapy Practice[edit|edit source]

Physical therapists work with patients at risk for and with diagnosed DVT across the continuum of care. For this reason, the American Physical Therapy Association (APTA) has developed clinical practice guidelines (CPG)[19]to facilitate decision making in the prevention and management of LE DVT in adults. The following table outlines the 5 responsibilities of physical therapists (PTs) with actionable recommendations:

PT Responsibilities Actionable Recommendations
(1) Prevention of VTE
  • Encourage patient mobility and physical activity at the individual and institutional level.
  • Recommend/use mechanical compression for individuals at moderate or high risk for DVT
  • Consult with the physician about medication for individuals at moderate or high risk for DVT
  • Provide education on DVT prevention (leg exercises, ambulation, hydration, etc)
  • Provide education on the risk factors, signs and symptoms, and consequences of DVT
(2) Screening for LE DVT
  • Screen for DVT risk using Well's Criteria or the preferred risk assessment model of the treating institution.
  • Communicate screening results and relevant clinical signs and symptoms to the medical team.
  • Provide education on the importance of seeking medical attention for suspected DVT.
(3) Making prudent decisions regarding safe mobility in conjunction with the health care team
  • Advocate for diagnostic testing and wait the results before mobilizing patients with suspected DVT
  • Screen for fall-risk when a patient is on anticoagulation therapy
  • Engage patients with known DVT in early mobilization. Recommendations for how and when it is safe to mobilize a patient with known DVT depends on patient fall-risk the medical treatment being used:
Medical Treatment Safe Mobilization Guidelines
Anticoagulation
  1. Verify initiation of anticoagulation and type.
  2. Determine if therapeutic levels of anticoagulation have been achieved.
  3. Mobilize the patient once he/she is in a therapeutic range.*
印度河流域文明过滤器
  1. Verify placement of an IVC filter.
  2. Mobilize the patient once he/she is hemodynamically stable.*
Out of bed ordered for a patient with no anticoagulation therapy or IVC filter
  1. Consult with the medical team regarding mobility vs continued bed rest.
(4) Prevention of long-term consequences of LE DVT
  • Engage patients with known DVT in safe mobilization (review section 3 of this table for details).
  • Recommend/use mechanical compression.
  • Provide education on the risks and benefits of mobilization following DVT.
(5) Patient education & shared decision making
  • Patient education should be given throughout the DVT prevention and management process.
  • Patients should have the autonomy to decide if they want to engage in recommended prevention and treatment measures.

*NOTE: Execution of the above recommendations should be done in line with institution-specific policies. Hillegass et al[19]offer adecision making algorithmthat may be helpful in the absence of or as a reference point for updating health care system protocols)

Differential Diagnosis[edit|edit source]

Below is a non-exhaustive list for the differential diagnosis of calf pain in patients with suspected LE DVT:[20][21]

Resources[edit|edit source]

Presentations[edit|edit source]

http://www.eimqa.com/Fellowship/FellowPresent/JogodkaVTE.mov 鉴别诊断和静脉血栓栓塞.png
鉴别诊断和静脉血栓栓塞

This presentation, created by Carleen Jogodka as part of theOMPT Fellowship, discusses differential diagnosis for venous thromboembolism.

View the presentation

References[edit|edit source]

  1. 1.001.011.021.031.041.051.061.071.081.091.10Kesieme E, Kesieme C, Jebbin N, Irekpita E, Dongo A. Deep vein thrombosis: a clinical review. J Blood Med 2011; 2:59–69.
  2. 2.02.12.22.32.4Waheed SM, Kudaravalli P, Hotwagner DT.Deep vein thrombosis (DVT). StatPearls [Internet]. 2020 Aug 10. Available from:https://www.ncbi.nlm.nih.gov/books/NBK507708/(last accessed 25.10.2020)
  3. 3.03.1Joffe H, Kucher N, Tapson V, Goldhaber S. Upper-extremity deep vein thrombosis: a prospective registry of 593 patients. Circulation 2004; 110: 1605-1611
  4. 4.04.14.2Kearon C. Natural history of venous thromboembolism. Seminars in Vascular Medicine 2001; 01(1): 027-038
  5. Wells PS, Hirsh J, Anderson DR, Lensing AW, Foster G, Kearon C, Weitz J, D'Ovidio R, Cogo A, Prandoni P. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345(8961):1326-1330
  6. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349:1227–1235
  7. Wells PS, Anderson DR, Bormanis J, Guy F, Mitchell M, Gray L, Clement C, Robinson KS, Lewandowski B. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350(9094):1795-1798
  8. 8.08.1Geersing GJ, Zuithoff NPA, Kearon C, Anderson DR, Cate-Hoek T, Elf JL, Bates SM, Hoes AW, Kraaijenhagen RA, Oudega R, Schutgens RE, Stevens SM, Woller SC, Wells PS, Moons KG. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ 2014; 348:g1340
  9. Modi S, Deisler R, Gozel K, Reicks P, Irwin E, Brunsvold M, Banton K, Beilman GJ. Wells criteria for DVT is a reliable clinical tool to assess the risk of deep venous thrombosis in trauma patients. World J Emerg Surg. 2016; 11: 24
  10. Silveira PC, Ip IK, Goldhaber SZ, Piazza G, Benson CB, Khorasani R. Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting. JAMA Intern Med 2015; 175(7):1112-7
  11. 11.011.1Heil J, Miesbach W, Vogl T, Bechstein WO, Reinisch A. Deep vein thrombosis of the upper extremity: A systematic review. Dtsch Arztebl Int 2017; 114(14): 244–249
  12. Riddle DL, Wells PS. Diagnosis of Lower-Extremity Deep Vein Thrombosis in Outpatients. Physical Therapy. 84 (8); 729-735.
  13. 13.013.1Snow V, Qaseem A, Barry P, et al. (2007). "Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians". Ann. Intern. Med. 146 (3): 204–10.
  14. Watson L, Armon M (2004). "Thrombolysis for acute deep vein thrombosis". Cochrane Database Syst Rev: CD002783
  15. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, Laporte S, Faivre R, Charbonnier B, Barral F, Huet Y, Simonneau G (1998). "A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group". N Engl J Med 338 (7): 409–15.
  16. Aissaoui N, Martins E, Mouly S, Wever S, Meune C. A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both. Int J Cardiol 2009;137:37–41
  17. 17.017.1Kahn SR, Shrier I, Kearon C. Physical activity in patients with deep venous thrombosis: a systematic review. Thromb Res 2008; 122:763–773
  18. Snow V, Qaseem A, Barry P, et al. (2007). "Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians". Ann. Intern. Med. 146 (3): 204–10.
  19. 19.019.1Hillegass E, Puthoff M, Frese EM, Thigpen M, Sobush DC, Auten B. Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism: Evidence-Based Clinical Practice Guideline. Phys Ther 2016; 96(2):143-66
  20. Dutton. Orthopaedic Examination, Evaluation, and Intervention. McGraw Hill; 2004. pg 261, 1338, 1367.
  21. Urbano F. Homans' Sign in the Diagnosis of Deep Venous Thrombosis. Hospital Physician 2001. 22-24